Know Your Risk: Assessment at Screening for Breast Cancer - Pilot Study
Completed · Not applicable
Conditions studied: Breast Neoplasms
In brief
The purpose of this pilot study is to evaluate a decision support website (RealRisks) designed to inform patients about breast cancer chemoprevention. It is coupled with a physician-centered (BNAV) decision support website as part of clinical workflow in the primary care setting. The investigator hypothesizes that improving accuracy of breast cancer risk perception and understanding of the risks/benefits of chemoprevention will enhance informed decision-making and uptake of breast cancer prevention strategies in the primary care setting.
Key facts
- Study ID
- NCT02954900
- Run by
- Columbia University
- People needed
- 40
- Starts
- 2016-03-15
- Expected to finish
- 2018-10-01
- Last updated by the study team
- 2021-01-08
Who can join
Age: 35 and older, up to 75. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- 5-year breast risk of 1.67% or lifetime risk of 20% according to the Gail model
- The participant understands and is willing to provide informed consent in English or Spanish
- Has a primary care provider at Columbia University Medical Center (CUMC) / New York-Presbyterian Hospital
You may not qualify if…
- Prior use of a selective estrogen receptor modulator (SERM) or aromatase inhibitor (AI) for chemoprevention
- Prior history of breast cancer
Where it is running
- Columbia University Medical Center — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.